XML 19 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash Flows From Operating Activities:    
Net loss $ (15,442) $ (21,164)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 14,944 2,499
Amortization of debt discount 736 248
Unrealized loss (gain) on investments in equity securities 308 (438)
Realized loss on investments in equity securities   805
Realized loss (gain) on available-for-sale debt securities 77 (10)
Stock-based compensation expense 11,163 6,355
Loss on disposal of property and equipment 125 214
Provision for bad debt 263 64
Changes in operating assets and liabilities:    
Accounts receivable (6,564) (749)
Inventories (2,980) (3)
Prepaid expenses and other current assets 2,722 151
Deposits 210 (99)
Change in operating lease right-of-use assets and lease liabilities 303 61
Accounts payable and other accrued expenses (2,334) 6,365
Accrued compensation and related expenses 1,245 651
Deferred revenue (137) (131)
Deferred tax liability 873 27
Net cash provided by (used) in operating activities 5,512 (5,154)
Cash Flows From Investing Activities:    
Purchases of property and equipment (15,556) (5,119)
Software development costs (757)  
Purchases of short-term investments (292,280) (136,293)
Sales/maturities of short-term investments 41,000 142,276
MVE net working capital settlement (500)  
Acquisition of CTSA and F-airGate (5,040)  
Patent and trademark costs (150) (116)
Net cash (used in) provided by investing activities (273,283) 748
Cash Flows From Financing Activities:    
Proceeds from exercise of stock options and warrants 5,986 8,312
Proceeds from public offering, net of $17.7 million in offering costs 269,825  
Proceeds from the issuance of convertible senior notes   115,000
Payment of deferred financing costs   (4,118)
Repayment of finance lease liabilities (44) (52)
Net cash provided by financing activities 275,767 119,142
Effect of exchange rate changes on cash and cash equivalents (1,189) 16
Net change in cash and cash equivalents 6,807 114,752
Cash and cash equivalents - beginning of period 36,873 47,235
Cash and cash equivalents - end of period 43,680 161,987
Supplemental Disclosure of Non-Cash Financing Activities:    
Conversion of Series C Preferred Stock to common stock 765  
Cost of Series C Preferred stock conversion included in additional paid-in-capital and accounts payable and accrued liabilities 1,800  
CRYOPDP goodwill adjustment included in deferred tax liability 930  
CRYOPDP goodwill adjustment included in fixed assets 70  
Fair value adjustment of CTSA contingent consideration included in goodwill and contingent consideration accrual 112  
Note valuation adjustment included in note payable and goodwill 284  
Net unrealized (loss)/gain on available-for-sale securities (1,544) 251
Reclassification of realized (loss)/gain on available-for-sale debt securities to earnings (10) 19
Purchase of equipment through capital lease obligations   205
Fixed assets included in accounts payable and accrued liabilities $ 1,554 327
Financing costs included in accounts payable and accrued liabilities   $ 473